Početna › Veliki depresivni poremećaj › Oklahoma
Kliničke studije za Veliki depresivni poremećaj u državi Oklahoma
12 studija za Veliki depresivni poremećaj traži sudionike na lokacijama u državi Oklahoma.
Gradovi u državi Oklahoma
Službeni tekst studije (engleski)
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Conrad Clinical Research, Edmond
- Sooner Clinical Research, Oklahoma City
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Conrad Clinical Research, Edmond
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06559306A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Sooner Clinical Research, Oklahoma City
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07076407A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Pahl Pharmaceutical Professionals Llc, Oklahoma City
U tijeku regrutacijaFaza 3
Od 18 do 74 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06775379A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Edmond
- Neurocrine Clinical Site, Oklahoma City
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. srp 2026. · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Edmond
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. srp 2026. · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Edmond
- Clinical Research Site, Oklahoma City
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 24. srp 2026. · NCT07484217A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Sooner Clinical Research /ID# 277659, Oklahoma City
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 15. lip 2026. · NCT07276997Neural Response to Inflammatory Challenge in Major Depressive Disorder
- Laureate Institute for Brain Research, Tulsa
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
Od 18 do 65 godina · Oba spola · Ažurirano 21. tra 2026. · NCT04751331Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #107, Oklahoma City
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 20. sij 2026. · NCT06633016Study of ALTO-300 in MDD
- Site 195, Oklahoma City
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 24. srp 2025. · NCT05922878A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Edmond
- Clinical Research Site, Oklahoma City
U tijeku regrutacijaFaza 4
Od 18 do 65 godina · Oba spola · Ažurirano 23. sij 2025. · NCT06223880Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.